ArticleThe Lancet regional health. Western Pacific2024

Efficacy and safety of visepegenatide as an add-on therapy to metformin in patients with type 2 diabetes: a randomised, double-blind, parallel, placebo-controlled, phase 3 study.

Xiaoling Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.